Han-Lin Hsu

2023

Understanding the medication experience of patients with advanced non-small cell lung cancer taking epidermal growth factor receptor-tyrosine kinase inhibitors: A phenomenological study

Wen, M. J., Hsu, H. L., Chang, C. L., Wang, J. H., Kuo, C. N., Hsin, Y. C. & Chang, E. H., 5月 2023, 於: PLoS ONE. 18, 5 MAY, e0286333.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

2022

Human Papillomavirus Oncoproteins Confer Sensitivity to Cisplatin by Interfering with Epidermal Growth Factor Receptor Nuclear Trafficking Related to More Favorable Clinical Survival Outcomes in Non-Small Cell Lung Cancer

Wang, J. L., Lee, W. J., Fang, C. L., Hsu, H. L., Chen, B. J. & Liu, H. E., 11月 2022, 於: Cancers. 14, 21, 5333.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

2 引文斯高帕斯（Scopus）

Tuberculosis treatment delay and nosocomial exposure remain important risks for patients undergoing regular hemodialysis

Lu, M., Sue, Y. M., Hsu, H. L., Zhang, J. F., Liu, Y. J., Yen, Y. C., Yu, T. Y., Yu, M. C. & Lee, C. H., 10月 2022, 於: Journal of Microbiology, Immunology and Infection. 55, 5, p. 926-934 9 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

1 引文斯高帕斯（Scopus）

2021

Aryl hydrocarbon receptor defect attenuates mitogen‐activated signaling through leucine‐rich repeats and immunoglobulin‐like domains 1 (Lrig1)‐dependent egfr degradation

Hsu, H. L., Chen, H. K., Tsai, C. H., Liao, P. L., Chan, Y. J., Lee, Y. C., Lee, C. C. & Li, C. H., 9月 2021, 於: International journal of molecular sciences. 22, 18, 9988.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

2 引文斯高帕斯（Scopus）

2020

Advantage in privacy protection by using synchronous video observed treatment enhances treatment adherence among patients with latent tuberculosis infection

Chen, S. H., Wang, I., Hsu, H. L., Huang, C. C., Liu, Y. J., Putri, D. U. & Lee, C. H., 9月 2020, 於: Journal of Infection and Public Health. 13, 9, p. 1354-1359 6 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

8 引文斯高帕斯（Scopus）

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers might be associated with lung adenocarcinoma risk: a nationwide population-based nested case-control study

Hsu, H. L., Lee, C. H., Chen, C. H., Zhan, J. F. & Wu, S. Y., 2020, 於: American Journal of Translational Research. 12, 10, p. 6615-6625 11 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

5 引文斯高帕斯（Scopus）

Ex vivo expansion and drug sensitivity profiling of circulating tumor cells from patients with small cell lung cancer

Lee, H. L., Chiou, J. F., Wang, P. Y., Lu, L. S., Shen, C. N., Hsu, H. L., Burnouf, T., Ting, L. L., Chou, P. C., Chung, C. L., Lee, K. L., Shiah, H. S., Liu, Y. L. & Chen, Y. J., 11月 2020, 於: Cancers. 12, 11, p. 1-17 17 p., 3394.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

25 引文斯高帕斯（Scopus）

2019

Chloramphenicol induces autophagy and inhibits the hypoxia inducible factor-1 alpha pathway in non-small cell lung cancer cells

Hsu, H. L., Liao, P. L., Cheng, Y. W., Huang, S. H., Wu, C. H., Li, C. H. & Kang, J. J., 1月 1 2019, 於: International Journal of Molecular Sciences. 20, 1, 157.

研究成果: 雜誌貢獻 › 文章 › 同行評審

9 引文斯高帕斯（Scopus）

Three-dimensional conformal radiotherapy-based or intensity-modulated radiotherapy-based concurrent chemoradiotherapy in patients with thoracic esophageal squamous cell carcinoma

Lin, W. C., Chang, C. L., Hsu, H. L., Yuan, K. S. P., Wu, A. T. H. & Wu, S. Y., 10月 1 2019, 於: Cancers. 11, 10, 1529.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

8 引文斯高帕斯（Scopus）

2018

Efficacy of thoracic radiotherapy in patients with stage IIIB–IV epidermal growth factor receptor-mutant lung adenocarcinomas who received and responded to tyrosine kinase inhibitor treatment

Yen, Y. C., Hsu, H. L., Chang, J. H., Lin, W. C., Chang, Y. C., Chang, C. L., Chow, J. M., Yuan, K. S. P., Wu, A. T. H. & Wu, S. Y., 10月 2018, 於: Radiotherapy and Oncology. 129, 1, p. 52-60 9 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

26 引文斯高帕斯（Scopus）

Prognostic value of localization of epidermal growth factor receptor in lung adenocarcinoma

Wang, J. L., Fang, C. L., Tzeng, Y. T., Hsu, H. L., Lin, S. E., Yu, M. C., Bai, K. J., Wang, L. S. & Liu, H. E., 6月 28 2018, 於: Journal of Biomedical Science. 25, 1, 53.

研究成果: 雜誌貢獻 › 文章 › 同行評審

5 引文斯高帕斯（Scopus）

2017

Dose escalation intensity-modulated radiotherapy-based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma

Chang, C. L., Tsai, H. C., Lin, W. C., Chang, J. H., Hsu, H. L., Chow, J. M., Yuan, K. S. P., Wu, A. T. H. & Wu, S. Y., 10月 2017, 於: Radiotherapy and Oncology. 125, 1, p. 73-79 7 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

70 引文斯高帕斯（Scopus）

Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques

Yen, Y-C., Chang, J. H., Lin, W. C., Chiou, J. F., Chang, Y. C., Chang, C. L., Hsu, H. L., Chow, J. M., Yuan, K. S. P., Wu, A. T. H. & Wu, S. Y., 6月 1 2017, 於: Cancer. 123, 11, p. 2043-2053 11 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

47 引文斯高帕斯（Scopus）

Efficacy of postoperative radiotherapy in patients with pathological stage N2 epidermal growth factor receptor wild type adenocarcinoma and squamous cell carcinoma lung cancer

Lin, Y-K., Hsu, H. L., Lin, W. C., Chang, J. H., Chang, Y-C., Chang, C. L., Yuan, K. S. P., Wu, A. T. H. & Wu, S-Y., 2017, 於: Oncotarget.

研究成果: 雜誌貢獻 › 文章 › 同行評審

2 引文斯高帕斯（Scopus）

Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma

Lin, W. C., Ding, Y. F., Hsu, H. L., Chang, J. H., Yuan, K. S. P., Wu, A. T. H., Chow, J. M., Chang, C. L., Chen, S. U. & Wu, S. Y., 10月 15 2017, 於: Cancer. 123, 20, p. 3904-3915 12 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

35 引文斯高帕斯（Scopus）

Vertebral tuberculosis complicated with retropharyngeal, parathoracic, and huge iliopsoas abscess, successfully treated with image-guided percutaneous drainage

Tang, V. K., Hsu, H. L., Hsieh, T. C. & Lee, W. S., 4月 2017, 於: Journal of Microbiology, Immunology and Infection. 50, 2, p. 263-264 2 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

2 引文斯高帕斯（Scopus）

2016

Evaluation of a modified direct agar proportion method for testing susceptibility of Mycobacterium tuberculosis from MGIT samples

Yu, F. L., Lee, J. C., Wang, M. S., Hsu, H. L., Chen, T. T., Cheng, C. L., Yang, Y. Y., Wang, G. C. & Yu, M. C., 2月 1 2016, 於: Journal of Microbiology, Immunology and Infection. 49, 1, p. 60-65 6 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

4 引文斯高帕斯（Scopus）

2015

Annexin A2 in renal cell carcinoma: Expression, function, and prognostic significance1These authors contributed equally to this work

Yang, S. F., Hsu, H. L., Chao, T. K., Hsiao, C. J., Lin, Y. F. & Cheng, C. W., 1月 1 2015, 於: Urologic Oncology: Seminars and Original Investigations. 33, 1, p. 22.e11-22.e21

研究成果: 雜誌貢獻 › 文章 › 同行評審

31 引文斯高帕斯（Scopus）

2014

MicroRNA-224 suppresses colorectal cancer cell migration by targeting Cdc42

Ke, T. W., Hsu, H. L., Wu, Y. H., Chen, W. T. L., Cheng, Y. W. & Cheng, C. W., 2014, 於: Disease Markers. 2014, 617150.

研究成果: 雜誌貢獻 › 文章 › 同行評審

44 引文斯高帕斯（Scopus）

Multiple Analytical Approaches Demonstrate a Complex Relationship of Genetic and Nongenetic Factors with Cisplatin- and Carboplatin-Induced Nephrotoxicity in Lung Cancer Patients

Liu, H. E., Bai, K. J., Hsieh, Y. C., Yu, M. C., Lee, C-N., Chang, J. H., Hsu, H. L., Lu, P. C. & Chen, H. Y., 2014, 於: BioMed Research International. 2014, 937429.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

16 引文斯高帕斯（Scopus）

2012

Recurrent bacteremia caused by the Acinetobacter calcoaceticus- Acinetobacter baumannii complex

Lai, C. C., Hsu, H. L., Tan, C. K., Tsai, H. Y., Cheng, A., Liu, C. Y., Huang, Y. T., Liao, C. H., Sheng, W. H. & Hsueh, P. R., 9月 1 2012, 於: Journal of Clinical Microbiology. 50, 9, p. 2982-2986 5 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

19 引文斯高帕斯（Scopus）

2011

Association of low activity of UGT1A7 with Lung Cancer in Taiwan: A preliminary case control study

Lee, J. A., Liu, H. E., Huang, W. I., Lee, C-N., Yu, M. C., Bai, K. J., Chang, J. H., Hsu, H. L., Lu, P. C. & Chen, H. Y., 12月 2011, 於: Journal of Food and Drug Analysis. 19, 4, p. 403-409

研究成果: 雜誌貢獻 › 文章 › 同行評審

1 引文斯高帕斯（Scopus）

Clinical and microbiological characteristics of urine culture-confirmed genitourinary tuberculosis at medical centers in Taiwan from 1995 to 2007

Hsu, H. L., Lai, C. C., Yu, M. C., Yu, F. L., Lee, J. C., Chou, C. H., Tan, C. K., Yang, P. C. & Hsueh, P. R., 3月 2011, 於: European Journal of Clinical Microbiology and Infectious Diseases. 30, 3, p. 319-326 8 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

10 引文斯高帕斯（Scopus）

Mixed infection with Beijing and non-Beijing strains in pulmonary tuberculosis in Taiwan: Prevalence, risk factors, and dominant strain

Wang, J. Y., Hsu, H. L., Yu, M. C., Chiang, C. Y., Yu, F. L., Yu, C. J., Lee, L. N. & Yang, P. C., 8月 2011, 於: Clinical Microbiology and Infection. 17, 8, p. 1239-1245 7 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

24 引文斯高帕斯（Scopus）

2010

Hepatitis associated with prothionamide for treatment of multidrug-resistant tuberculosis

Hsu, H. L., Bai, K. J., Chiang, Y. C., Lin, S. J. & Yu, M. C., 12月 2010, 於: Journal of the Formosan Medical Association. 109, 12, p. 923-927 5 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

5 引文斯高帕斯（Scopus）

2009

Effect of Pterygium Surgery on refractive spherocylinder power and corneal topography

Wu, P. L., Kuo, C. N., Hsu, H. L. & Lai, C. H., 1月 1 2009, 於: Ophthalmic Surgery Lasers and Imaging. 40, 1, p. 32-37 6 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

15 引文斯高帕斯（Scopus）

Multidrug-resistant tuberculosis

Hsu, H. L., Bai, K. J., Lin, S. J., Lee, C-N. & Yu, M. C., 12月 2009, 於: Journal of Internal Medicine of Taiwan. 20, 6, p. 524-531 8 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

1 引文斯高帕斯（Scopus）

NAT2 fast acetylator genotypes are associated with an increased risk for lung cancer with wildtype epidermal growth factor receptors in Taiwan

Lee, C-N., Yu, M. C., Bai, K. J., Chang, J. H., Fang, C. L., Hsu, H. L., Huang, B. S., Lu, P. C. & Liu, H. E., 4月 2009, 於: Lung Cancer. 64, 1, p. 9-12 4 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

12 引文斯高帕斯（Scopus）

許 翰琳

研究成果

搜尋結果

許翰琳